Dimensional Fund Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $281K | Buy |
|
|||||
|
2024
Q4 | $326K | Sell |
|
|||||
|
2024
Q3 | $430K | Sell |
|
|||||
|
2024
Q2 | $410K | Sell |
|
|||||
|
2024
Q1 | $468K | Sell |
|
|||||
|
2023
Q4 | $2.13M | Sell |
|
|||||
|
2023
Q3 | $1.95M | Sell |
|
|||||
|
2023
Q2 | $4.41M | Sell |
|
|||||
|
2023
Q1 | $4.07M | Sell |
|
|||||
|
2022
Q4 | $9.89K | Sell |
|
|||||
|
2022
Q3 | $8.85M | Sell |
|
|||||
|
2022
Q2 | $21M | Sell |
|
|||||
|
2022
Q1 | $33.7M | Buy |
|
|||||
|
2021
Q4 | $27.1M | Buy |
|
|||||
|
2021
Q3 | $20.4M | Buy |
|
|||||
|
2021
Q2 | $16.2M | Buy |
|
|||||
|
2021
Q1 | $19M | Sell |
|
|||||
|
2020
Q4 | $48M | Sell |
|
|||||
|
2020
Q3 | $30.4M | Sell |
|
|||||
|
2020
Q2 | $30.5M | Sell |
|
|||||
|
2020
Q1 | $18.1M | Buy |
|
|||||
|
2019
Q4 | $15.8M | Buy |
|
|||||
|
2019
Q3 | $13.5M | Buy |
|
|||||
|
2019
Q2 | $10.3M | Buy |
|
|||||
|
2019
Q1 | $9.6M | Buy |
|
|||||
|
2018
Q4 | $5.94M | Buy |
|
|||||
|
2018
Q3 | $4.73M | Buy |
|
|||||
|
2018
Q2 | $587K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1.16M | Buy |
|
|||||
|
2016
Q4 | $793K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $6.41M | Buy |
|
|||||
|
2015
Q3 | $5.01M | Buy |
|
|||||
|
2015
Q2 | $2.32M | Buy |
|